Unitract rolls out
Tuesday, 15 July, 2008
The global product roll-out for Unilife's [ASX: UNI] Unitract 1mL safety syringes has begun.
To support the roll-out, Unilife has appointed strategic partner Kindly Enterprise Development (KDL) Group as distribution partner for a number of regions.
Unilife has already received and processed sales orders from KDL for the syringe.
KDL has been granted exclusive rights to sell the syringe in selected regions in China, the Middle East, Eastern Europe, Africa and Central and South America, and non-exclusive rights to sell them in Germany and Austria.
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
